Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Apr-24 5:42 PM View:  | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 15-Apr-24 | Payment of Exercise | 7,027 | $10.66 | $74,907.80 | (9%) 80.95K to 73.93K | 11% |
| 03-Apr-24 6:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Apr-24 | Option Exercise | 7,500 | $8.61 | $64,575.00 | < 1% 886.65K to 894.15K | 10% |
| 03-Apr-24 6:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Apr-24 | Market Option Sale | 7,500 | $11.67 | $87,495.80 | (< 1%) 894.15K to 886.65K | 19% |
| 19-Mar-24 5:52 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 15-Mar-24 | Payment of Exercise | 13,375 | $11.48 | $153,545.00 | (1%) 900.03K to 886.65K | 18% |
| 11-Mar-24 5:36 PM View: | Sblendorio Glenn Director | Amicus Therapeutics, Inc. (FOLD) | 07-Mar-24 | Option Exercise | 15,000 | $2.80 | $42,000.00 | 22% 68.6K to 83.6K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Sale | 7,500 | $13.40 | $100,500.00 | (11%) 66.79K to 59.29K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Exercise | 7,500 | $2.80 | $21,000.00 | 13% 59.29K to 66.79K | |
| 06-Mar-24 10:00 PM View: | Raab Michael Director | Amicus Therapeutics, Inc. (FOLD) | 05-Mar-24 | Option Exercise | 15,000 | $2.80 | $42,000.00 | 22% 68.6K to 83.6K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-24 | Option Exercise | 7,500 | $2.80 | $21,000.00 | 13% 59.29K to 66.79K | |
| 06-Mar-24 10:00 PM View: | McGlynn Margaret G Director | Amicus Therapeutics, Inc. (FOLD) | 04-Mar-24 | Option Sale | 7,500 | $13.29 | $99,675.00 | (11%) 66.79K to 59.29K | |
| 05-Mar-24 5:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Option Exercise | 15,833 | $10.54 | $166,904.00 | 2% 871.22K to 887.05K | (10%) |
| 05-Mar-24 5:14 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Private Option Sale | 15,833 | $13.14 | $208,017.00 | (2%) 887.05K to 871.22K | |
| 05-Mar-24 5:14 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Mar-24 | Private Sale | 29,181 | $13.35 | $389,543.00 | (4%) 667.55K to 638.37K | |
| 20-Feb-24 5:23 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Payment of Exercise | 94,969 | $14.00 | $1,329,570.00 | (12%) 794.14K to 699.17K | |
| 20-Feb-24 5:23 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Sale | 31,614 | $13.81 | $436,551.00 | (5%) 699.17K to 667.55K | |
| 20-Feb-24 5:20 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Private Sale | 4,427 | $14.00 | $61,978.00 | (2%) 258.09K to 253.66K | |
| 20-Feb-24 5:21 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 15-Feb-24 | Private Sale | 4,167 | $14.00 | $58,338.00 | (< 1%) 875.39K to 871.22K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 07-Feb-24 | Option Sale | 29,600 | $13.00 | $384,818.00 | (7%) 412.25K to 382.65K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 07-Feb-24 | Option Exercise | 29,600 | $5.16 | $152,736.00 | 8% 382.65K to 412.25K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 06-Feb-24 | Option Exercise | 400 | $5.16 | $2,064.00 | < 1% 382.65K to 383.05K | |
| 08-Feb-24 4:40 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 06-Feb-24 | Option Sale | 400 | $13.00 | $5,200.00 | (< 1%) 383.05K to 382.65K | |
| 05-Feb-24 7:22 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Payment of Exercise | 21,596 | $12.67 | $273,621.00 | (3%) 847.35K to 825.75K | |
| 05-Feb-24 7:22 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Sale | 31,614 | $12.62 | $398,918.00 | (4%) 825.75K to 794.14K | |
| 05-Feb-24 7:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Private Option Sale | 15,833 | $12.56 | $198,858.00 | (2%) 891.22K to 875.39K | |
| 05-Feb-24 7:22 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 01-Feb-24 | Option Exercise | 15,833 | $10.54 | $166,904.00 | 2% 875.39K to 891.22K | (10%) |
| 24-Jan-24 5:20 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 22-Jan-24 | Private Sale | 55,327 | $12.36 | $683,958.00 | (6%) 902.67K to 847.35K | |
| 18-Jan-24 5:09 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 16-Jan-24 | Private Sale | 31,614 | $12.78 | $404,106.00 | (3%) 934.29K to 902.67K | |
| 11-Jan-24 6:33 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 10-Jan-24 | Sale | 31,614 | $13.65 | $431,452.00 | (3%) 965.9K to 934.29K | |
| 09-Jan-24 6:07 PM View: | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Sale | 1,337 | $14.00 | $18,718.00 | (2%) 82.29K to 80.95K | |
| 11-Jan-24 6:34 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Payment of Exercise | 23,577 | $13.65 | $321,826.00 | (3%) 898.96K to 875.39K | |
| 09-Jan-24 6:08 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Sale | 1,384 | $14.00 | $19,376.00 | (< 1%) 268.09K to 266.7K | |
| 11-Jan-24 6:34 PM View: | Castelli Jeff Chief Development Officer | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Payment of Exercise | 10,005 | $13.65 | $136,568.00 | (3%) 372.81K to 362.8K | |
| 11-Jan-24 6:35 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Payment of Exercise | 8,614 | $13.65 | $117,581.00 | (3%) 266.7K to 258.09K | |
| 11-Jan-24 6:33 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Payment of Exercise | 36,865 | $13.65 | $503,207.00 | (4%) 1.0M to 965.9K | |
| 11-Jan-24 6:35 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 09-Jan-24 | Payment of Exercise | 12,000 | $13.65 | $163,800.00 | (3%) 394.65K to 382.65K | |
| 09-Jan-24 6:07 PM View: | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 08-Jan-24 | Private Sale | 30,767 | $14.00 | $430,827.00 | (27%) 113.06K to 82.29K | |
| 09-Jan-24 6:08 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 08-Jan-24 | Private Sale | 8,726 | $14.00 | $122,164.00 | (3%) 276.81K to 268.09K | |
| 05-Jan-24 6:01 PM View: | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 1,296 | $13.44 | $17,418.20 | (1%) 114.35K to 113.06K | |
| 05-Jan-24 6:01 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 2,692 | $13.44 | $36,180.50 | (< 1%) 279.51K to 276.81K | |
| 05-Jan-24 6:02 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 10,659 | $13.44 | $143,257.00 | (1%) 1.01M to 1.0M | |
| 05-Jan-24 6:03 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 3,380 | $13.44 | $45,427.20 | (< 1%) 398.03K to 394.65K | |
| 05-Jan-24 6:03 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 7,368 | $13.44 | $99,025.90 | (< 1%) 906.33K to 898.96K | |
| 05-Jan-24 6:04 PM View: | Castelli Jeff Chief Development Officer | Amicus Therapeutics, Inc. (FOLD) | 04-Jan-24 | Payment of Exercise | 3,127 | $13.44 | $42,026.90 | (< 1%) 375.93K to 372.81K | |
| 04-Jan-24 6:24 PM View: | Rosenberg Ellen Chief Legal Officer | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 15,397 | $13.53 | $208,321.00 | (4%) 413.43K to 398.03K | |
| 04-Jan-24 6:35 PM View: | Campbell Bradley L President and CEO Director | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 41,474 | $13.53 | $561,143.00 | (4%) 947.8K to 906.33K | |
| 04-Jan-24 6:36 PM View: | Castelli Jeff Chief Development Officer | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 14,083 | $13.53 | $190,543.00 | (4%) 390.01K to 375.93K | |
| 05-Jan-24 6:01 PM View: | Prout Samantha Whiteman Chief Accounting Officer | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 8,142 | $13.53 | $110,161.00 | (7%) 122.5K to 114.35K | |
| 04-Jan-24 6:26 PM View: | Clark David Michael Chief People Officer | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 11,650 | $13.53 | $157,624.00 | (4%) 291.16K to 279.51K | |
| 04-Jan-24 6:33 PM View: | Crowley John F Executive Chairman Director | Amicus Therapeutics, Inc. (FOLD) | 03-Jan-24 | Payment of Exercise | 108,417 | $13.53 | $1,466,880.00 | (10%) 1.12M to 1.01M | |
| 04-Jan-24 6:17 PM View: | Harford Simon N.R. Chief Financial Officer | Amicus Therapeutics, Inc. (FOLD) | 02-Jan-24 | Grant | 57,392 | -- | -- | 54% 106.97K to 164.37K |
